Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -128.69% is 93% above its 5-year average of -1742.00%, around the middle of its 5-year range (-120878.18%–87277.21%).
137.10% below its 12-month average of 346.85%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2025 (2025-12-31): 0.00%.
NET PROFIT MARGIN
-128.69%
NET PROFIT MARGIN AVG TTM
346.85%
NET PROFIT MARGIN AVG 3Y
6981.12%
NET PROFIT MARGIN AVG 5Y
-1742.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-137.10%
CURRENT VS 3Y AVG
-101.84%
CURRENT VS 5Y AVG
+92.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 560 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Apollomics, Inc.
Market Cap
$54.90M
Net Profit Margin
-128.69%
TTM Avg
346.85%
3Y Avg
6981.12%
5Y Avg
-1742.00%
Market Cap
$55.94M
Net Profit Margin
-86687.50%
TTM Avg
-43373.76%
3Y Avg
-21686.88%
5Y Avg
-14457.92%
Market Cap
$53.13M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$53.01M
Net Profit Margin
-5668.62%
TTM Avg
-3356.71%
3Y Avg
-1974.47%
5Y Avg
-1414.89%
Market Cap
$52.99M
Net Profit Margin
N/A
TTM Avg
-24.71%
3Y Avg
-12.36%
5Y Avg
-8.24%
Market Cap
$57.33M
Net Profit Margin
-69.27%
TTM Avg
-45.15%
3Y Avg
-54.32%
5Y Avg
-40.58%
Market Cap
$51.72M
Net Profit Margin
-4722.25%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apollomics, Inc. (APLM) | $54.90M | -128.69% | 346.85% | 6981.12% | -1742.00% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $55.94M | -86687.50% | -43373.76% | -21686.88% | -14457.92% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $53.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImageneBio Inc (IMA)vs › | $53.01M | -5668.62% | -3356.71% | -1974.47% | -1414.89% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.99M | N/A | -24.71% | -12.36% | -8.24% |
| Spectral AI, Inc. (MDAI)vs › | $57.33M | -69.27% | -45.15% | -54.32% | -40.58% |
| Microbot Medical Inc. (MBOT)vs › | $51.72M | -4722.25% | 0.00% | 0.00% | 0.00% |
| biote Corp. (BTMD)vs › | $50.28M | 3.19% | 7.83% | 4.22% | 10.88% |
| eXoZymes, Inc. (EXOZ)vs › | $51.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| INmune Bio, Inc. (INMB)vs › | $51.28M | -91866.00% | -196225.86% | -104777.73% | -90977.38% |
Operating Margin
-111.5%
Net Profit Margin
-128.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | 0.00% |
| 2025-06-30 | -147.48% |
| 2024-12-31 | 1188.03% |
| 2024-06-30 | -1991.29% |
| 2023-12-31 | -6578.68% |
| 2023-06-30 | -30879.92% |
| 2022-12-31 | 87277.21% |
| 2022-06-30 | -574.29% |
| 2021-12-31 | 53422.64% |
| 2021-06-30 | -120878.18% |
| 2020-12-31 | 0.00% |
| 2020-06-30 | -2355.50% |
| 2019-12-31 | 0.00% |
| 2019-06-30 | 0.00% |
